Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ANZEMET (dolasétron mésilate)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ANZEMET (dolasétron mésilate)

Medicine - Posted on Dec 01 2010 - Updated on Jun 12 2019
Active substance (DCI)
  • dolasétron mésilate
history (3)
  • 12/1/10

    ANZEMET (dolasétron mésilate)

    ANZEMET (dolasétron mésilate)
    icône flèche
  • 2/15/06

    ANZEMET 100 mg/5 ml, solution injectable 1 ampoule(s) en verre de 5 ml : 343 207-1 ANZEMET 200 mg, comprimé pelliculé plaquette(s) thermoformée(s) PVC PVDC aluminium de 1 comprimé(s) : 343 320-2

    ANZEMET 100 mg/5 ml, solution injectable 1 ampoule(s) en verre de 5 ml : 343 207-1 ANZEMET 200 mg, comprimé pelliculé plaquette(s) thermoformée(s) PVC PVDC aluminium de 1 comprimé(s) : 343 320-2
    icône flèche
  • 2/21/01

    ANZEMET 200 mg, comprimé pelliculé (boîte de 1) ANZEMET 100 mg/5 ml, solution injectable (boîte de 1)

    ANZEMET 200 mg, comprimé pelliculé (boîte de 1) ANZEMET 100 mg/5 ml, solution injectable (boîte de 1)
    icône flèche
Technical information
ATC code
  • A04AA04
Manufacturer
Laboratoire SANOFI-AVENTIS FRANCE
Presentation

ANZEMET 100 mg/5 ml, solution injectable - 1 ampoule de 5 ml- Code CIP : 3432071

All our publications
    Cancers - miscellaneous Drug therapy Esophageal and gastrointestinal diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
c6CEzpZfma30bQzE